TY - JOUR
T1 - Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects on IL-4 and IFN-gamma and selective involvement of TFN-alpha receptor-1
AU - Lardon, F
AU - Snoeck, HW
AU - Berneman, ZN
AU - Van Tendeloo, VFI
AU - Nijs, G
AU - Lenjou, M
AU - Henckaerts, E
AU - Boeckxtaens, CJ
AU - Vandenabeele, P
AU - Kestens, LL
AU - Van Bockstaele, DR
AU - Vanham, GLEE
N1 - FTX: Abonnement
PY - 1997
Y1 - 1997
N2 - We report the generation of dendritic cells (DC) starting from CD34+ bone marrow (BM) progenitor cells, using a two-stage culture system in which, besides granulocyte–macrophage colony-stimulating factor (GM-CSF) and tumour necrosis factor-α (TNF-α), stem-cell factor (SCF) was added during the first 5 days, while interleukin-4 (IL-4) and/or interferon-γ (IFN-γ) were added during the secondary culture period of 9 days. Addition of IL-4 favoured the outgrowth of CD1a+, HLA-DR+, CD4+, CD40+, CD80+ but CD14− cells with dendritic morphology and strong antigen-presenting capacity. Addition of IFN-γ selectively induced HLA-DR and CD86 but did not up-regulate CD1a expression or antigen-presenting capacity of the differentiated cells. An antagonism between IL-4 and IFN-γ could further be confirmed in that, as compared with IL-4 alone, the simultaneous addition of IL-4 and IFN-γ to GM-CSF plus TNF-α during maturation reduced both the phenotypical (CD1a, CD4, CD40) and functional characteristics of DC. Using receptor-specific TNF-α mutants, we investigated the relative involvement of TNF-α receptors R1 and R2 in the generation of DC. The induction of CD1a and HLA-DR, as well as the increase in allostimulatory capacity were dependent on TNF-R1 triggering, whereas triggering through TNF-R2 had no measurable effect. We conclude first, that the expansion of DC from BM progenitors could most effectively be enhanced in a two-stage culture assay using SCF, GM-CSF, TNF-α and IL-4; second, that the effect of TNF-α in DC generation involves signalling via the TNF-R1 receptor; and third, that IFN-γ counteracts some of the effects of IL-4 in DC generation.
AB - We report the generation of dendritic cells (DC) starting from CD34+ bone marrow (BM) progenitor cells, using a two-stage culture system in which, besides granulocyte–macrophage colony-stimulating factor (GM-CSF) and tumour necrosis factor-α (TNF-α), stem-cell factor (SCF) was added during the first 5 days, while interleukin-4 (IL-4) and/or interferon-γ (IFN-γ) were added during the secondary culture period of 9 days. Addition of IL-4 favoured the outgrowth of CD1a+, HLA-DR+, CD4+, CD40+, CD80+ but CD14− cells with dendritic morphology and strong antigen-presenting capacity. Addition of IFN-γ selectively induced HLA-DR and CD86 but did not up-regulate CD1a expression or antigen-presenting capacity of the differentiated cells. An antagonism between IL-4 and IFN-γ could further be confirmed in that, as compared with IL-4 alone, the simultaneous addition of IL-4 and IFN-γ to GM-CSF plus TNF-α during maturation reduced both the phenotypical (CD1a, CD4, CD40) and functional characteristics of DC. Using receptor-specific TNF-α mutants, we investigated the relative involvement of TNF-α receptors R1 and R2 in the generation of DC. The induction of CD1a and HLA-DR, as well as the increase in allostimulatory capacity were dependent on TNF-R1 triggering, whereas triggering through TNF-R2 had no measurable effect. We conclude first, that the expansion of DC from BM progenitors could most effectively be enhanced in a two-stage culture assay using SCF, GM-CSF, TNF-α and IL-4; second, that the effect of TNF-α in DC generation involves signalling via the TNF-R1 receptor; and third, that IFN-γ counteracts some of the effects of IL-4 in DC generation.
KW - B780-tropical-medicine
KW - Immunology
KW - Bone marrow
KW - Cytokines
KW - Dendritic cells
KW - CD
KW - Tumor necrosis factor
KW - TNF
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:A1997XP52400008
U2 - 10.1046/j.1365-2567.1997.00295.x
DO - 10.1046/j.1365-2567.1997.00295.x
M3 - A1: Web of Science-article
SN - 0019-2805
VL - 91
SP - 553
EP - 559
JO - Immunology
JF - Immunology
IS - 4
ER -